Drug-induced nephrotoxicity in children: Pharmacologically based prevention of long-term impairment

Pediatric Drugs

Volumn 9, Issue 3, 2007, Pages 139-142

  Koren, Gideon ^a,b   Chen, Nancy ^b   Aleksa, Katerina ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CISPLATIN; CYCLOSPORIN; CYCLOSPORIN A; IFOSFAMIDE; MELATONIN; MESNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADVERSE OUTCOME; CANCER; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG INDUCED NEPHROTOXICITY; DRUG POTENCY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; GLOMERULAR DYSFUNCTION; HUMAN; KIDNEY GRAFT REJECTION; NEPHROTOXICITY; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMIC MYCOSIS;

AMPHOTERICIN B; CHILD; CYCLOSPORINE; HUMANS; IFOSFAMIDE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; TIME FACTORS;

EID: 34249809761     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200709030-00001     Document Type: Note

References (19)

1. Chen N, Aleksa K, Woodland C, et al. Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 2006; 21: 160-8
2. Loebstein R, Atanackovic G, Bishai R, et al. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 1999; 39: 454-61
3. Holler B, Omar SA, Farid MD, et al. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics 2004; 113: e608-16
4. Kshirsagar NA, Pandya SK, Kirodian GB, et al. Liposomal drug delivery system from laboratory to clinic. J Postgrad Med 2005; 51 Suppl. 1: S5-15
5. Sabra R, Zeinoun N, Sharaf LH, et al. Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity. Pharmacol Toxicol 2001; 88 (4): 168-75
6. Gibbs WJ, Drew RH, Perfect JR. Liposomal amphotericin B: clinical experience and perspectives. Expert Rev Anti Infect Ther 2005; 3: 167-81
7. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia: National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340: 764-71
8. Sandler ES, Mustafa MM, Tkaczewski I, et al. Use of amphotericin B colloidal dispersion in children. J Pediatr Hematol Oncol 2000; 22: 242-6
9. Loo RM, Ariyarajah V, Oh C, et al. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients. Pediatr Transplant 2006; 10: 55-9
10. Tonshoff B, Hocker B. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 2006; 10: 721-9
11. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 2273-80
12. Woodland C, Ito S, Granvil CP, et al. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci 2000; 68: 109-17
13. Springate J, Taub M. Ifosfamide toxicity in cultured proximal renal tubule cells. Pediatr Nephrol 2007; 22: 358-65
14. Aleksa K, Halachmi N, Ito S, et al. Renal ontogeny of ifosfamide nehrotoxicity. J Lab Clin Med 2004; 144: 285-93
15. Aleksa K, Halachmi N, Ito S, et al. A tubule cell model for ifosfamide nephrotoxicity. Can J Physiol Pharmacol 2005; 83: 499-508
16. Sener G, Sehirli O, Yegen BC, et al. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats. J Pineal Res 2004; 37: 17-25
17. Chen N, Aleksa K, Woodland C, et al. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity. Can J Clin Pharmacol 2006; 13: e189
18. Chen N, Aleksa K, Woodland C, et al. The in vivo effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity in rats. Can J Clin Pharmacol. In press
19. Morgan LR, Donley PJ, Harrison EF, et al. The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung. Semin Oncol 1982; 9 (4 Suppl. 1): 71-4